136 related articles for article (PubMed ID: 26391112)
1. Influence of clone and deletion size on outcome in chronic lymphocytic leukemia patients with an isolated deletion 13q in a population-based analysis in British Columbia, Canada.
Huang SJ; Gillan TL; Gerrie AS; Hrynchak M; Karsan A; Ramadan K; Smith AC; Toze CL; Bruyere H
Genes Chromosomes Cancer; 2016 Jan; 55(1):16-24. PubMed ID: 26391112
[TBL] [Abstract][Full Text] [Related]
2. Interstitial 13q14 deletions detected in the karyotype and translocations with concomitant deletion at 13q14 in chronic lymphocytic leukemia: different genetic mechanisms but equivalent poorer clinical outcome.
Puiggros A; Venturas M; Salido M; Blanco G; Fernandez-Rodriguez C; Collado R; Valiente A; Ruiz-Xivillé N; Carrió A; Ortuño FJ; Luño E; Calasanz MJ; Ardanaz MT; Piñán MÁ; Talavera E; González MT; Ortega M; Marugán I; Ferrer A; Gimeno E; Bellosillo B; Delgado J; Hernández JÁ; Hernández-Rivas JM; Espinet B; ;
Genes Chromosomes Cancer; 2014 Sep; 53(9):788-97. PubMed ID: 24915757
[TBL] [Abstract][Full Text] [Related]
3. 13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia.
Dal Bo M; Rossi FM; Rossi D; Deambrogi C; Bertoni F; Del Giudice I; Palumbo G; Nanni M; Rinaldi A; Kwee I; Tissino E; Corradini G; Gozzetti A; Cencini E; Ladetto M; Coletta AM; Luciano F; Bulian P; Pozzato G; Laurenti L; Forconi F; Di Raimondo F; Marasca R; Del Poeta G; Gaidano G; Foà R; Guarini A; Gattei V
Genes Chromosomes Cancer; 2011 Aug; 50(8):633-43. PubMed ID: 21563234
[TBL] [Abstract][Full Text] [Related]
4. Impact of trisomy 12, del(13q), del(17p), and del(11q) on the immunophenotype, DNA ploidy status, and proliferative rate of leukemic B-cells in chronic lymphocytic leukemia.
Quijano S; López A; Rasillo A; Sayagués JM; Barrena S; Sánchez ML; Teodosio C; Giraldo P; Giralt M; Pérez MC; Romero M; Perdiguer L; Orfao A
Cytometry B Clin Cytom; 2008 May; 74(3):139-49. PubMed ID: 18061951
[TBL] [Abstract][Full Text] [Related]
5. Chronic lymphocytic leukemia with del13q14 as the sole abnormality: dynamic prognostic estimate by interphase-FISH.
Orlandi EM; Bernasconi P; Pascutto C; Giardini I; Cavigliano PM; Boni M; Zibellini S; Cazzola M
Hematol Oncol; 2013 Sep; 31(3):136-42. PubMed ID: 23060227
[TBL] [Abstract][Full Text] [Related]
6. The prognostic significance of 13q deletions of different sizes in patients with B-cell chronic lymphoproliferative disorders: a retrospective study.
Yi S; Li H; Li Z; Xiong W; Liu H; Liu W; Lv R; Yu Z; Zou D; Xu Y; An G; Qiu L
Int J Hematol; 2017 Sep; 106(3):418-425. PubMed ID: 28439775
[TBL] [Abstract][Full Text] [Related]
7. Biallelic losses of 13q do not confer a poorer outcome in chronic lymphocytic leukaemia: analysis of 627 patients with isolated 13q deletion.
Puiggros A; Delgado J; Rodriguez-Vicente A; Collado R; Aventín A; Luño E; Grau J; Hernandez JÁ; Marugán I; Ardanaz M; González T; Valiente A; Osma M; Calasanz MJ; Sanzo C; Carrió A; Ortega M; Santacruz R; Abrisqueta P; Abella E; Bosch F; Carbonell F; Solé F; Hernández JM; Espinet B;
Br J Haematol; 2013 Oct; 163(1):47-54. PubMed ID: 23869550
[TBL] [Abstract][Full Text] [Related]
8. An Anomaly with Potential as a New Prognostic Marker in CLL with del(13q): Gain of 16p13.3.
Isik S; Gunden G; Gunduz E; Akay OM; Aslan A; Ozen H; Cilingir O; Erzurumluoglu Gokalp E; Kocagil S; Artan S; Gulbas Z; Durak Aras B
Cytogenet Genome Res; 2021; 161(10-11):479-487. PubMed ID: 34915466
[TBL] [Abstract][Full Text] [Related]
9. Clinico-pathological impact of cytogenetic subgroups in B-cell chronic lymphocytic leukemia: experience from India.
Amare PS; Gadage V; Jain H; Nikalje S; Manju S; Mittal N; Gujral S; Nair R
Indian J Cancer; 2013; 50(3):261-7. PubMed ID: 24061469
[TBL] [Abstract][Full Text] [Related]
10. A comprehensive evaluation of the prognostic significance of 13q deletions in patients with B-chronic lymphocytic leukaemia.
Van Dyke DL; Shanafelt TD; Call TG; Zent CS; Smoley SA; Rabe KG; Schwager SM; Sonbert JC; Slager SL; Kay NE
Br J Haematol; 2010 Feb; 148(4):544-50. PubMed ID: 19895615
[TBL] [Abstract][Full Text] [Related]
11. A higher percentage of cells with 13q deletion predicts worse outcome in Chinese patients with chronic lymphocytic leukemia carrying isolated 13q deletion.
Miao Y; Miao Y; Shi K; Sun Q; Zhao SS; Xia Y; Qin SC; Qiu HR; Yang H; Xu H; Zhu HY; Wu JZ; Wu W; Cao L; Wang L; Fan L; Xu W; Li JY
Ann Hematol; 2018 Sep; 97(9):1663-1669. PubMed ID: 29736587
[TBL] [Abstract][Full Text] [Related]
12. Chronic lymphocytic leukaemia profiled for prognosis using a fluorescence in situ hybridisation panel.
Reddy KS
Br J Haematol; 2006 Mar; 132(6):705-22. PubMed ID: 16487171
[TBL] [Abstract][Full Text] [Related]
13. Monoallelic and biallelic deletions of 13q14.3 in chronic lymphocytic leukemia: FISH vs miRNA RT-qPCR detection.
Smonskey MT; Block AW; Deeb G; Chanan-Khan AA; Bernstein ZP; Miller KC; Wallace PK; Starostik P
Am J Clin Pathol; 2012 Apr; 137(4):641-6. PubMed ID: 22431542
[TBL] [Abstract][Full Text] [Related]
14. Clonal evolution as detected by interphase fluorescence in situ hybridization is associated with worse overall survival in a population-based analysis of patients with chronic lymphocytic leukemia in British Columbia, Canada.
Huang SJ; Bergin K; Smith AC; Gerrie AS; Bruyere H; Dalal CB; Sugioka DK; Hrynchak M; Ramadan KM; Karsan A; Gillan TL; Toze CL
Cancer Genet; 2017 Jan; 210():1-8. PubMed ID: 28212806
[TBL] [Abstract][Full Text] [Related]
15. Combining cytogenetic and epigenetic approaches in chronic lymphocytic leukemia improves prognosis prediction for patients with isolated 13q deletion.
Bagacean C; Le Dantec C; Berthou C; Tempescul A; Saad H; Bordron A; Zdrenghea M; Cristea V; Douet-Guilbert N; Renaudineau Y
Clin Epigenetics; 2017; 9():122. PubMed ID: 29209431
[TBL] [Abstract][Full Text] [Related]
16. Interphase cytogenetics in chronic lymphocytic leukemia.
Garcia-Marco JA; Price CM; Catovsky D
Cancer Genet Cytogenet; 1997 Mar; 94(1):52-8. PubMed ID: 9078291
[TBL] [Abstract][Full Text] [Related]
17. Population-based characterization of the genetic landscape of chronic lymphocytic leukemia patients referred for cytogenetic testing in British Columbia, Canada: the role of provincial laboratory standardization.
Gerrie AS; Huang SJ; Bruyere H; Dalal C; Hrynchak M; Karsan A; Ramadan KM; Smith AC; Tyson C; Toze CL; Gillan TL
Cancer Genet; 2014; 207(7-8):316-25. PubMed ID: 25441686
[TBL] [Abstract][Full Text] [Related]
18. MiRNA expression profile of chronic lymphocytic leukemia patients with 13q deletion.
Hernández-Sánchez M; Rodríguez-Vicente AE; Hernández JÁ; Lumbreras E; Sarasquete ME; Martín AÁ; Benito R; Vicente-Gutiérrez C; Robledo C; Heras Nde L; Rodríguez JN; Alcoceba M; Coca AG; Aguilar C; González M; Hernández-Rivas JM
Leuk Res; 2016 Jul; 46():30-6. PubMed ID: 27111859
[TBL] [Abstract][Full Text] [Related]
19. Importance of immunoglobulin heavy chain variable region mutational status in del(13q) chronic lymphocytic leukemia.
Gladstone DE; Swinnen L; Kasamon Y; Blackford A; Gocke CD; Griffin CA; Meade JB; Jones RJ
Leuk Lymphoma; 2011 Oct; 52(10):1873-81. PubMed ID: 21851216
[TBL] [Abstract][Full Text] [Related]
20. The prognostic difference of monoallelic versus biallelic deletion of 13q in chronic lymphocytic leukemia.
Garg R; Wierda W; Ferrajoli A; Abruzzo L; Pierce S; Lerner S; Keating M; O'Brien S
Cancer; 2012 Jul; 118(14):3531-7. PubMed ID: 22139735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]